2019 The 4th ACSSS | CABS Career Development Workshop & Career Fair

Welcome to The 4th ACSSS | CABS Career Development Workshop & Career Fair on March 17th, 2019!

The Association of Chinese Students and Scholars at Stanford (ACSSS) Postdoc Group, together with Chinese-American Bio/Pharmaceutical Society (CABS) are hosting a Career Fair on March 17th (Sun), 2019. Please join us if you are interested in:

  • Seeking industrial and academic full-time or internship opportunities in the Bay Area and China

  • Exploring career development resources at Stanford University

  • Identifying your transferable skills and developing your own career path

  • Boosting your professional networks and meeting potential referrals

  • One-to-one conversation/interview with industrial representatives

When: March 17th (Sunday), 12:30 pm - 6:00 pm

Where: Li Ka Shing Learning and Knowledge Center, Stanford University 

291 Campus Drive, Stanford, California 94305

LKSC Lobby (Check-in) 

LK101/102 LK005 (Career Fair),

LK120 (Welcome speech; Keynote talks)

Company list

Weekend Free Parking: Roth Way Garage and Stock Farm Garage

For more information or vendor booth reservation/sponsorship, please contact us at

We’re looking forward to seeing you on March 17th!

Company descriptions (in alphabetical order):

  • Alibaba Group 阿里巴巴 is a Chinese multinational conglomerate specializing in e-commerceretailInternet and technology. Founded April 4, 1999, the company provides consumer-to-consumer (C2C), business-to-consumer (B2C),and business-to-business (B2B) sales services via web portals, as well as electronic payment services, shopping search engines and cloud computing services.

  • Amgen 安进 is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

  • LLC is the largest for-profit genealogy company in the world, and it operates a network of genealogical, historical record and genetic genealogy websites.

  • Apostle Inc. 使徒 is a biotechnology start-up headquartered in Sunnyvale, CA. We are in the business of the research, development, licensing, and sales of novel AI (Artificial Intelligence)-Enabled Nanotechnologies and the related intellectual properties, products, and services for diagnosis and treatment of human diseases.

  • Applied StemCell Inc. (ASC) is a fast-growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community.

  • Beijing Genomics Institute (BGI) 华大基因 was established in 1999 with participation in the original Human Genome Project. Now as one of the world’s largest genomics organizations, BGI is experienced in genomic research, commercial NGS services and sequencer manufacturing. We are committed to providing solutions to address the research, pharmaceutical, and clinical markets.

  • Carmot Therapeutics is pioneering the discovery and development of innovative drugs for the treatment of metabolic diseases, cancer, and inflammation. Carmot’s vision is to become a leader in drug discovery by generating superior drugs for challenging therapeutic targets.

  • Gan & Lee Pharmaceuticals 甘李药业 is a high-tech biopharmaceutical company specialized in research, development, production, and commercialization of insulin and its analogues, leading in the diabetes market in China.

  • Gilead Sciences, Inc., 吉利德科学公司 is a biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIVhepatitis Bhepatitis C, and influenza, including Harvoniand Sovaldi.

  • Hengenix Biotech (Hengenix) focuses on delivering safe and effective yet affordable medicines to treat a range of chronic and life-threatening diseases.  Affiliated to Shanghai Henlius Biotech, a top biopharma company in China, Hengenix has a successful track record in moving multiple research leads into clinical stage with a rapid speed, including the first biosimilar approval in China, 2 NDA filings and 27 IND approval in 9 years.

  • American Technologies Corporation 京东 is the largest e-commerce company by revenue in China, with recent plans to strengthen our leadership position as a technology-driven company with focus on big data, AI technology and smart logistics. Our JD Silicon Valley R&D Center focuses on developing and enhancing new and existing technologies to improve user experience and expand the company’s offerings.

  • Kelun Pharmaceutical 科伦药业 is the market leader of injectable and infusion technologies. We are committed to R&D for small-molecule NCEs and biological NBEs, biosimilars, generic drugs, and new drug delivery systems (NDDS) in oncology, diabetes, hepatitis, cardiovascular and other major disease areas.

  • MabPlex provides global CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs and bispecifics. We offer our partners contract services from DNA to finished drug product. Our technical expertise allows us to provide effective high quality solutions for our partners biomanufacturing needs.

  • MedAbome, Inc. is a biotech company located in San Francisco Bay Area that is focused on the discovery and development of innovative therapeutic monoclonal antibodies (mAbs) and immunotherapy technologies for the treatment of major human diseases such as cancers, cardiovascular diseases and autoimmune diseases.

  • MORE Health’s mission is to offer you and your family access to the best medical minds in the world, exactly at the moment you need their experience; when you are faced with decisions regarding a serious, life-changing illness.

  • Morrison & Foerster 美富律师事务所 is an international law firm with 16 offices located throughout the United StatesAsia, and Europe. The firm has over 1,000 lawyers who advise clients across a range of industries and practices, including intellectual property, patent litigation, corporate/M&A, business restructuring, and securities

  • New York Life Insurance Company (NYLIC) is the third-largest life insurance company in the United States, the largest mutual life insurance company in the United States.

  • NVIGEN is a nanotechnology empowered personalized medicine innovator. We are focusing on the development of a comprehensive circulating bio-marker biopsy technology, Nanopsy™, to predict cancer recurrence at the earliest possible time and guide the most effective personalized therapy.

  • Paragon Genomics develops and commercializes rapid, easy-to-use, ultra-high multiplex PCR-based target enrichment solutions for Next-Generation Sequencing (NGS).

  • Senti Biosciences is a team of bioengineers, scientists, and entrepreneurs on a mission to treat the most complex and challenging diseases. Led by pioneers in synthetic biology and computation, Senti is using the latest techniques in the fields to build the future of gene and cell-based therapies.

  • University of Electronic Science and Technology of China 电子科技大学 is a national key university directly under the Ministry of Education of China. UESTC was included as one of the first universities into "Project 211" in 1997, and then the nation's “Project 985” in 2001.

  • Visa Research aims at complementing an already substantial investment in technology development with a focus on the scientific foundations of existing, emerging, and future commerce related technologies across broad time horizons. With the establishment of a formal research organization and the associated long-term commitment to technology research, Visa joins the ranks of a small number of industry leaders with both the insight and ability to substantially influence and systemically impact the future.

  • Wuxi AppTec 药明康德, established in December 2000, is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with global operations. Our services are designed to help customers shorten the discovery and development time, lower the cost of drug and medical device R&D through cost-effective and efficient solutions.

  • XMotors 小鹏汽车 is a fully-owned subsidiary of XPENG Motors, developer of the electric vehicle with cutting edge AI features. XPENG Motors is dedicated to applying new technologies, crafts and business models to create AI cars liked by young people, and to refresh user's experience.